{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:34Z","timestamp":1787020174919,"version":"build-2736575974"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11647-2","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:09:14Z","timestamp":1761739754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Correlates of virological non-suppression among children and adolescents aged 5\u201319 years on Dolutegravir-based regimens attending Gulu regional referral hospital, Northern Uganda: a mixed methods cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"Vincent Okech","family":"Moro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Mbaziira","family":"Ssenkusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Matovu","family":"Kiweewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"issue":"1","key":"11647_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s42269-022-00961-3","volume":"46","author":"RD Mchomvu","year":"2022","unstructured":"Mchomvu RD, Hussein AK, Matee M. Determinants of viral load non-suppression among HIV-positive children and adolescents attending care and treatment clinics in Tabora region, Tanzania. Bull Natl Res Cent. 2022;46(1):271. https:\/\/doi.org\/10.1186\/s42269-022-00961-3.","journal-title":"Bull Natl Res Cent"},{"issue":"3","key":"11647_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40471-021-00268-3","volume":"8","author":"WLA Koay","year":"2021","unstructured":"Koay WLA, Kose-Otieno J, Rakhmanina N. HIV drug resistance in children and adolescents: always a challenge?? Curr Epidemiol Rep. 2021;8(3):97\u2013107. https:\/\/doi.org\/10.1007\/s40471-021-00268-3.","journal-title":"Curr Epidemiol Rep"},{"key":"11647_CR3","unstructured":"UNAIDS. Seizing the moment: tackling entrenched inequalities to end epidemics. Global AIDS Update; 2020."},{"key":"11647_CR4","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1744783\/v1","author":"E Namusoke-Magongo","year":"2022","unstructured":"Namusoke-Magongo E, Nakanwagi M, Adoa D, Nyamitoro I, Arinaitwe I, Nazziwa E, Nkolo E K, Nabitaka V, Chimulwa T, Kiranda E, Ayitewala A, Ochora E N, Katureebe C, Musinguzi J J. Rapid paediatric and adolescent Anti-retroviral therapy optimization in uganda, 2020\u20132021: A National implementation success during a raging Covid19 pandemic. Rev. 2022. https:\/\/doi.org\/10.21203\/rs.3.rs-1744783\/v1. Preprint.","journal-title":"Rev"},{"key":"11647_CR5","unstructured":"World Health Organization. HIV drug resistance report 2021. World Health Organization; 2021. https:\/\/apps.who.int\/iris\/handle\/10665\/349340. WHO IRIS."},{"key":"11647_CR6","unstructured":"World Health Organization. Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines: supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. World Health Organization; 2018."},{"issue":"4","key":"11647_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/COH.0000000000000378","volume":"12","author":"M Penazzato","year":"2017","unstructured":"Penazzato M, Palladino C, Sugandhi N. Prioritizing the most needed formulations to accelerate paediatric antiretroviral therapy scale-up. Curr Opin HIV AIDS. 2017;12(4):369\u201376.","journal-title":"Curr Opin HIV AIDS"},{"issue":"7","key":"11647_CR8","doi-asserted-by":"publisher","first-page":"e25325","DOI":"10.1002\/jia2.25325","volume":"22","author":"AN Phillips","year":"2019","unstructured":"Phillips AN, Cambiano V, Nakagawa F, Bansi-Matharu L, Wilson D, Jani I, Apollo T, Sculpher M, Hallett T, Kerr C, van Oosterhout JJ, Eaton JW, Estill J, Williams B, Doi N, Cowan F, Keiser O, Ford D, Hatzold K, Revill P. Cost-per-diagnosis as a metric for monitoring cost-effectiveness of HIV testing programmes in low-income settings in Southern africa: health economic and modelling analysis. J Int AIDS Soc. 2019;22(7):e25325. https:\/\/doi.org\/10.1002\/jia2.25325.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"11647_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12913-017-2009-6","volume":"17","author":"H Zakumumpa","year":"2017","unstructured":"Zakumumpa H, Bennett S, Ssengooba F. Alternative financing mechanisms for ART programs in health facilities in Uganda: a mixed-methods approach. BMC Health Serv Res. 2017;17(1):65. https:\/\/doi.org\/10.1186\/s12913-017-2009-6.","journal-title":"BMC Health Serv Res"},{"key":"11647_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003878","author":"JM Bacha","year":"2023","unstructured":"Bacha JM, Dlamini S, Anabwani F, Gwimile J, Kanywa JB, Farirai J, et al. Realizing the promise of dolutegravir in effectively treating children and adolescents living with HIV in real-world settings in 6 countries in Eastern and Southern Africa. Pediatr Infect Dis J. 2023. https:\/\/doi.org\/10.1097\/INF.0000000000003878.","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"11647_CR11","doi-asserted-by":"publisher","first-page":"e0270855","DOI":"10.1371\/journal.pone.0270855","volume":"17","author":"TP Gordon","year":"2022","unstructured":"Gordon TP, Talbert M, Mugisha MK, Herbert AE. Correlates associated with HIV viral suppression among adolescents in Kabale district, South Western Uganda. PLoS ONE. 2022;17(8):e0270855. https:\/\/doi.org\/10.1371\/journal.pone.0270855.","journal-title":"PLoS ONE"},{"issue":"1","key":"11647_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12887-021-02608-0","volume":"21","author":"P Kibalama Ssemambo","year":"2021","unstructured":"Kibalama Ssemambo P, Nalubega-Mboowa MG, Owora A, Serunjogi R, Kironde S, Nakabuye S, Ssozi F, Nannyonga M, Musoke P, Barlow-Mosha L. Virologic response of treatment experienced HIV-infected Ugandan children and adolescents on NNRTI based first-line regimen, previously monitored without viral load. BMC Pediatr. 2021;21(1):139. https:\/\/doi.org\/10.1186\/s12887-021-02608-0.","journal-title":"BMC Pediatr"},{"issue":"1","key":"11647_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/17450128.2020.1842954","volume":"16","author":"WE Brown","year":"2021","unstructured":"Brown WE, Malagala H, Bajunirwe F. Social support, gender and pill burden influence viral load suppression among HIV-infected adolescents and young adults in rural south-western Uganda. Vulnerable Child Youth Stud. 2021;16(1):86\u201397. https:\/\/doi.org\/10.1080\/17450128.2020.1842954.","journal-title":"Vulnerable Child Youth Stud"},{"issue":"1","key":"11647_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s41182-019-0135-z","volume":"47","author":"J Natukunda","year":"2019","unstructured":"Natukunda J, Kirabira P, Ong KIC, Shibanuma A, Jimba M. Virologic failure in HIV-positive adolescents with perfect adherence in Uganda: a cross-sectional study. Trop Med Health. 2019;47(1):8. https:\/\/doi.org\/10.1186\/s41182-019-0135-z.","journal-title":"Trop Med Health"},{"issue":"1","key":"11647_CR15","doi-asserted-by":"publisher","first-page":"e0246140","DOI":"10.1371\/journal.pone.0246140","volume":"16","author":"S Nabukeera","year":"2021","unstructured":"Nabukeera S, Kagaayi J, Makumbi FE, Mugerwa H, Matovu JKB. Correlates associated with virological non-suppression among HIV-positive children receiving antiretroviral therapy at the joint clinical research centre in lubowa, Kampala Uganda. PLoS ONE. 2021;16(1):e0246140. https:\/\/doi.org\/10.1371\/journal.pone.0246140.","journal-title":"PLoS ONE"},{"issue":"2","key":"11647_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/jpids\/piaa030","volume":"10","author":"NZ Bitwale","year":"2021","unstructured":"Bitwale NZ, Mnzava DP, Kimaro FD, Jacob T, Mpondo BCT, Jumanne S. Prevalence and correlates associated with virological treatment failure among children and adolescents on antiretroviral therapy attending HIV\/AIDS care and treatment clinics in Dodoma municipality, central Tanzania. J Pediatr Infect Dis Soc. 2021;10(2):131\u201340. https:\/\/doi.org\/10.1093\/jpids\/piaa030.","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"1","key":"11647_CR17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1186\/s12879-021-06459-z","volume":"21","author":"AKA Afrane","year":"2021","unstructured":"Afrane AKA, Goka BQ, Renner L, Yawson AE, Alhassan Y, Owiafe SN, Agyeman S, Sagoe KWC, Kwara A. HIV virological non-suppression and its associated correlates in children on antiretroviral therapy at a major treatment centre in Southern ghana: A cross-sectional study. BMC Infect Dis. 2021;21(1):731. https:\/\/doi.org\/10.1186\/s12879-021-06459-z.","journal-title":"BMC Infect Dis"},{"key":"11647_CR18","unstructured":"Wikipedia contributors. Gulu District. Wikipedia, The Free Encyclopedia. February 13. 2022, 07:49 UTC. Available at: https:\/\/en.wikipedia.org\/w\/index.php?title=Gulu_District&oldid=1071565565. Accessed November 26, 2022."},{"key":"11647_CR19","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1017\/S0950268821000637","volume":"149","author":"GAFS van Liere","year":"2021","unstructured":"van Liere GAFS, Lilian R, Dunlop J, Tait C, Rees K, Mabitsi M, Ranoto L, Struthers HE, McIntyre JA, Peters RPH. High rate of loss to follow-up and virological non-suppression in HIV-infected children on antiretroviral therapy highlights the need to improve quality of care in South Africa. Epidemiol Infect. 2021;149:e88. https:\/\/doi.org\/10.1017\/S0950268821000637.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"11647_CR20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12887-022-03400-4","volume":"22","author":"C Jackson","year":"2022","unstructured":"Jackson C, Rehman AM, McHugh G, Gonzalez-Martinez C, Ngwira LG, Bandason T, Mujuru H, Odland JO, Corbett EL, Ferrand RA, Simms V. Risk correlates for sustained virological non-suppression among children and adolescents living with HIV in Zimbabwe and malawi: A secondary data analysis. BMC Pediatr. 2022;22(1):340. https:\/\/doi.org\/10.1186\/s12887-022-03400-4.","journal-title":"BMC Pediatr"},{"issue":"1","key":"11647_CR21","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s12879-017-2428-3","volume":"17","author":"L Bulage","year":"2017","unstructured":"Bulage L, Ssewanyana I, Nankabirwa V, Nsubuga F, Kihembo C, Pande G, Ario AR, Matovu JK, Wanyenze RK, Kiyaga C. Correlates associated with virological Non-suppression among HIV-Positive patients on antiretroviral therapy in uganda, August 2014\u2013July 2015. BMC Infect Dis. 2017;17(1):326. https:\/\/doi.org\/10.1186\/s12879-017-2428-3.","journal-title":"BMC Infect Dis"},{"key":"11647_CR22","unstructured":"Republic of Uganda. Consolidate guidelines for the prevention and treatment of HIV and AIDS in Uganda. 2020;"},{"key":"11647_CR23","unstructured":"Uganda Ministry of Health. Consolidated Guidelines on the prevention and treatment of HIV. 2018;"},{"key":"11647_CR24","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. World Health Organization; 2013. https:\/\/apps.who.int\/iris\/handle\/10665\/85321."},{"issue":"5","key":"11647_CR25","doi-asserted-by":"publisher","first-page":"e0232076","DOI":"10.1371\/journal.pone.0232076","volume":"15","author":"G Guest","year":"2020","unstructured":"Guest G, Namey E, Chen M. A simple method to assess and report thematic saturation in qualitative research. PLoS ONE. 2020;15(5):e0232076.","journal-title":"PLoS ONE"},{"key":"11647_CR26","unstructured":"Bernard HR, Wutich A, Ryan GW. Analyzing qualitative data: systematic approaches. SAGE; 2016."},{"key":"11647_CR27","doi-asserted-by":"crossref","unstructured":"Sandeloswski M. Sample size in qualitative research. Research in nursing & health. 1995 Apr;18(2):179-83","DOI":"10.1002\/nur.4770180211"},{"issue":"3","key":"11647_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/jan.13152","volume":"73","author":"L Nowell","year":"2017","unstructured":"Nowell L, Norris JM, Mrklas K, White DE. Mixed methods systematic review exploring mentorship outcomes in nursing academia. J Adv Nurs. 2017;73(3):527\u201344. https:\/\/doi.org\/10.1111\/jan.13152.","journal-title":"J Adv Nurs"},{"issue":"2","key":"11647_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"issue":"1","key":"11647_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-021-00408-1","volume":"18","author":"J Maena","year":"2021","unstructured":"Maena J, Banke-Thomas A, Mukiza N, Kuteesa CN, Kakumba RM, Kataike H, et al. Determinants of viral load non-suppression among adolescents in Mbale district, eastern rural Uganda. AIDS Res Ther. 2021;18(1):91. https:\/\/doi.org\/10.1186\/s12981-021-00408-1.","journal-title":"AIDS Res Ther"},{"issue":"9","key":"11647_CR31","doi-asserted-by":"publisher","first-page":"e0239087","DOI":"10.1371\/journal.pone.0239087","volume":"15","author":"R Opito","year":"2020","unstructured":"Opito R, Mpagi J, Bwayo D, Okello F, Mugisha K, Napyo A. Treatment outcome of the implementation of HIV test and treat policy at the AIDS support organization (TASO) Tororo clinic, Eastern Uganda: a retrospective cohort study. PLoS ONE. 2020;15(9):e0239087.","journal-title":"PLoS ONE"},{"issue":"20","key":"11647_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033737","volume":"102","author":"J Fokam","year":"2023","unstructured":"Fokam J, Nka AD, Mamgue Dzukam FY, Efakika Gabisa J, Bouba Y, Tommo Tchouaket MC, et al. Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: children at high risk of virological failure due to the lowly transition in pediatrics. Medicine (Baltimore). 2023a;102(20):e33737. https:\/\/doi.org\/10.1097\/MD.0000000000033737.","journal-title":"Medicine (Baltimore)"},{"key":"11647_CR33","doi-asserted-by":"publisher","unstructured":"Nyakato P, Schomaker M, Fatti G, Tanser F, Euvrard J, Sipambo N, Fox MP, Haas AD, Yiannoutsos CT, Davies M, Cornell M. Virologic non-suppression and early loss to follow up among pregnant and non\u2010pregnant adolescents aged 15\u201319 years initiating antiretroviral therapy in South africa: A retrospective cohort study. J Int AIDS Soc. 2022;25(1). https:\/\/doi.org\/10.1002\/jia2.25870.","DOI":"10.1002\/jia2.25870"},{"issue":"22","key":"11647_CR34","doi-asserted-by":"publisher","first-page":"14710","DOI":"10.3390\/ijerph192214710","volume":"19","author":"FK Munyayi","year":"2022","unstructured":"Munyayi FK, van Wyk B. Closing the HIV treatment gap for adolescents in windhoek, namibia: A retrospective analysis of correlates of viral Non-Suppression. Int J Environ Res Public Health. 2022;19(22):14710.","journal-title":"Int J Environ Res Public Health"},{"key":"11647_CR35","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. World Health Organization; 2016."},{"issue":"2","key":"11647_CR36","doi-asserted-by":"publisher","first-page":"e55747","DOI":"10.1371\/journal.pone.0055747","volume":"8","author":"MR Loutfy","year":"2013","unstructured":"Loutfy MR, Wu W, Letchumanan M, Bondy L, Antoniou T, Margolese S, Zhang Y, Rueda S, McGee F, Peck R. Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy. PLoS ONE. 2013;8(2):e55747.","journal-title":"PLoS ONE"},{"issue":"6","key":"11647_CR37","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/tmi.12694","volume":"21","author":"HC Duber","year":"2016","unstructured":"Duber HC, Roberts DA, Ikilezi G, Fullman N, Gasasira A, Gakidou E, Haakenstad A, Levine J, A., Achan J. Evaluating facility-based antiretroviral therapy programme effectiveness: A pilot study comparing viral load suppression and retention rates. Tropical Med Int Health. 2016;21(6):750\u20138.","journal-title":"Tropical Med Int Health"},{"issue":"5","key":"11647_CR38","doi-asserted-by":"publisher","first-page":"e0127235","DOI":"10.1371\/journal.pone.0127235","volume":"10","author":"A Billioux","year":"2015","unstructured":"Billioux A, Nakigozi G, Newell K, Chang LW, Quinn TC, Gray RH, et al. Durable suppression of HIV-1 after virologic monitoring-based antiretroviral adherence counseling in Rakai, Uganda. PLoS ONE. 2015;10(5):e0127235.","journal-title":"PLoS ONE"},{"key":"11647_CR39","doi-asserted-by":"publisher","DOI":"10.1101\/2023.05.17.23290106","author":"AA Maghembe","year":"2023","unstructured":"Maghembe AA, Boer MS, Marikias G, Amour C, Mahande MJ. HIV viral suppression and associated correlates among children and adolescents on a dolutegravir (DTG) based antiretroviral regimen in Tanzania mainland. medRxiv. 2023 May 25:2023-05. https:\/\/doi.org\/10.1101\/2023.05.17.23290106","journal-title":"HIV\/AIDS"},{"issue":"5","key":"11647_CR40","doi-asserted-by":"publisher","first-page":"586","DOI":"10.4103\/NJM.NJM_90_21","volume":"30","author":"M-L Orji","year":"2021","unstructured":"Orji M-L, Onyire N, Ojukwu J, Oyim-Elechi C. The outcome of intervention, characteristics, and determinants of treatment failure in HIV-infected adolescents on first-line antiretroviral therapy at a tertiary health institution, in South-east Nigeria. Niger J Med. 2021;30(5):586. https:\/\/doi.org\/10.4103\/NJM.NJM_90_21.","journal-title":"Niger J Med"},{"issue":"4","key":"11647_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019181","volume":"8","author":"MM Sisay","year":"2018","unstructured":"Sisay MM, Ayele TA, Gelaw YA, Tsegaye AT, Gelaye KA, Melak MF. Incidence and risk correlates of first-line antiretroviral treatment failure among human immunodeficiency virus-infected children in Amhara regional state, ethiopia: a retrospective follow-up study. BMJ Open. 2018;8(4):e019181.","journal-title":"BMJ Open"},{"issue":"4","key":"11647_CR42","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/QAI.0b013e3181cf4882","volume":"54","author":"SD Emmett","year":"2010","unstructured":"Emmett SD, Cunningham CK, Mmbaga BT, Kinabo GD, Schimana W, Swai ME, et al. Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study. JAIDS J Acquir Immune Defic Syndr. 2010;54(4):368\u201375.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"9","key":"11647_CR43","doi-asserted-by":"publisher","first-page":"679","DOI":"10.7196\/SAMJ.2019.v109i9.13462","volume":"109","author":"C Hendrickson","year":"2019","unstructured":"Hendrickson C, Evans D, Brennan AT, Patz S, Untiedt S, Bassett J, et al. Treatment outcomes among HIV-positive orphaned and non-orphaned children on antiretroviral therapy in Johannesburg, South Africa. South Afr Med J. 2019;109(9):679. https:\/\/doi.org\/10.7196\/SAMJ.2019.v109i9.13462.","journal-title":"South Afr Med J"},{"issue":"2","key":"11647_CR44","doi-asserted-by":"publisher","first-page":"e0191848","DOI":"10.1371\/journal.pone.0191848","volume":"13","author":"RC Vreeman","year":"2018","unstructured":"Vreeman RC, Ayaya SO, Musick BS, Yiannoutsos CT, Cohen CR, Nash D, Wabwire D, Wools-Kaloustian K, Wiehe SE. Adherence to antiretroviral therapy in a clinical cohort of HIV-infected children in East Africa. PLoS ONE. 2018;13(2):e0191848.","journal-title":"PLoS ONE"},{"issue":"1","key":"11647_CR45","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12879-015-0753-y","volume":"15","author":"D Nyogea","year":"2015","unstructured":"Nyogea D, Mtenga S, Henning L, Franzeck FC, Glass TR, Letang E, et al. Determinants of antiretroviral adherence among HIV positive children and teenagers in rural Tanzania: a mixed methods study. BMC Infect Dis. 2015;15(1):28. https:\/\/doi.org\/10.1186\/s12879-015-0753-y.","journal-title":"BMC Infect Dis"},{"key":"11647_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041998","author":"K Kikuchi","year":"2012","unstructured":"Kikuchi K, Poudel KC, Muganda J, Majyambere A, Otsuka K, Sato T, et al. High risk of ART non-adherence and delay of ART initiation among HIV positive double orphans in kigali, Rwanda. PLoS ONE. 2012. https:\/\/doi.org\/10.1371\/journal.pone.0041998.","journal-title":"PLoS ONE"},{"issue":"1","key":"11647_CR47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12879-019-4732-6","volume":"20","author":"AA Desta","year":"2020","unstructured":"Desta AA, Woldearegay TW, Futwi N, Gebrehiwot GT, Gebru GG, Berhe AA, Godefay H. HIV virological non-suppression and correlates associated with non-suppression among adolescents and adults on antiretroviral therapy in Northern ethiopia: A retrospective study. BMC Infect Dis. 2020;20(1):4. https:\/\/doi.org\/10.1186\/s12879-019-4732-6.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"11647_CR48","doi-asserted-by":"publisher","first-page":"e71407","DOI":"10.1371\/journal.pone.0071407","volume":"8","author":"JE Greig","year":"2013","unstructured":"Greig JE, Du Cros PA, Mills C, Ugwoeruchukwu W, Etsetowaghan A, Grillo A, Tayo-Adetoro A, Omiyale K, Spelman T, O\u2019Brien DP. Correlates of Raised viral load during antiretroviral therapy in patients with and without prior antiretroviral use: A Cross-Sectional study. PLoS ONE. 2013;8(8):e71407. https:\/\/doi.org\/10.1371\/journal.pone.0071407.","journal-title":"PLoS ONE"},{"issue":"2","key":"11647_CR49","doi-asserted-by":"publisher","first-page":"e0116144","DOI":"10.1371\/journal.pone.0116144","volume":"10","author":"K Jobanputra","year":"2015","unstructured":"Jobanputra K, Parker LA, Azih C, Okello V, Maphalala G, Kershberger B, Khogali M, Lujan J, Antierens A, Teck R, Ellman T, Kosgei R, Reid T. Correlates associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland. PLoS ONE. 2015;10(2):e0116144. https:\/\/doi.org\/10.1371\/journal.pone.0116144.","journal-title":"PLoS ONE"},{"issue":"5","key":"11647_CR50","doi-asserted-by":"publisher","first-page":"e0229550","DOI":"10.1371\/journal.pone.0229550","volume":"16","author":"A Abba","year":"2021","unstructured":"Abba A, Fokam J, Kamgaing RS, Yimga JF, Ka\u2019e AC, Nka AD, Tchouaket MCT, Chenwi CA, Semengue ENJ, Ndjolo A, Sosso SM. Correlation between the immuno-virological response and the nutritional profile of treatment-experienced HIV-infected patients in the East region of Cameroon. PLoS ONE. 2021;16(5):e0229550. https:\/\/doi.org\/10.1371\/journal.pone.0229550.","journal-title":"PLoS ONE"},{"key":"11647_CR51","unstructured":"Maertens JA. Barriers to Nutrition management among people living with HIV on Antiretroviral Therapy (Doctoral dissertation) , 2011."},{"key":"11647_CR52","unstructured":"Piwoz EG, Preble EA. HIV\/AIDS and nutrition: A review of the literature and recommendations for nutritional care and support in Sub-Saharan Africa. Support for Analysis and Research in Africa (SARA) Project; 2000."},{"issue":"0 2","key":"11647_CR53","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.1097\/QAD.0000000000000095","volume":"27","author":"BR Phelps","year":"2013","unstructured":"Phelps BR, Ahmed S, Amzel A, Diallo MO, Jacobs T, Kellerman SE, et al. Linkage, initiation and retention of children in the antiretroviral therapy cascade: an overview. AIDS. 2013;27(0 2):S207.","journal-title":"AIDS"},{"issue":"1","key":"11647_CR54","doi-asserted-by":"publisher","DOI":"10.3402\/gha.v6i0.19248","volume":"6","author":"M Sengayi","year":"2013","unstructured":"Sengayi M, Dwane N, Marinda E, Sipambo N, Fairlie L, Moultrie H. Correlates of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa. Glob Health Action. 2013;6(1):19248.","journal-title":"Glob Health Action"},{"issue":"7","key":"11647_CR55","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/j.1365-3156.2010.02539.x","volume":"15","author":"P Braitstein","year":"2010","unstructured":"Braitstein P, Katshcke A, Shen C, Sang E, Nyandiko W, Ochieng VO, et al. Retention of HIV\u2010infected and HIV\u2010exposed children in a comprehensive HIV clinical care programme in Western Kenya. Trop Med Int Health. 2010;15(7):833\u201341.","journal-title":"Trop Med Int Health"},{"key":"11647_CR56","unstructured":"Sidemo NB, Hebo SH. Nutritional status and its effect on treatment outcome among HIV-infected children receiving first-line antiretroviral therapy in Arba minch general hospital and Arba minch health center, Gamo zone, Southern ethiopia: retrospective cohort study. Nutrition and HIV\/AIDS-Implication for treatment, prevention and cure. IntechOpen; 2019."},{"issue":"1","key":"11647_CR57","doi-asserted-by":"publisher","first-page":"21922","DOI":"10.7448\/IAS.20.1.21922","volume":"20","author":"S Williams","year":"2017","unstructured":"Williams S, Renju J, Ghilardi L, Wringe A. Scaling a waterfall: a meta-ethnography of adolescent progression through the stages of HIV care in sub\u2010Saharan Africa. J Int AIDS Soc. 2017;20(1):21922.","journal-title":"J Int AIDS Soc"},{"issue":"11","key":"11647_CR58","doi-asserted-by":"publisher","first-page":"e0167492","DOI":"10.1371\/journal.pone.0167492","volume":"11","author":"SC Inzaule","year":"2016","unstructured":"Inzaule SC, Hamers RL, Kityo C, Rinke de Wit TF, Roura M. Long-term antiretroviral treatment adherence in HIV-infected adolescents and adults in Uganda: a qualitative study. PLoS ONE. 2016;11(11):e0167492.","journal-title":"PLoS ONE"},{"issue":"1","key":"11647_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-015-1265-5","volume":"15","author":"N Nabukeera-Barungi","year":"2015","unstructured":"Nabukeera-Barungi N, Elyanu P, Asire B, Katureebe C, Lukabwe I, Namusoke E, Musinguzi J, Atuyambe L, Tumwesigye N. Adherence to antiretroviral therapy and retention in care for adolescents living with HIV from 10 districts in Uganda. BMC Infect Dis. 2015;15(1):1\u201310.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"11647_CR60","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1089\/apc.2023.0017","volume":"37","author":"CE Kennedy","year":"2023","unstructured":"Kennedy CE, Zhao T, Vo AV, Nakubulwa R, Nabakka P, Jackson J, et al. High acceptability and perceived feasibility of long-acting injectable antiretroviral treatment among people living with HIV who are viremic and health workers in Uganda. AIDS Patient Care STDs. 2023;37(6):316\u201322.","journal-title":"AIDS Patient Care STDs"},{"key":"11647_CR61","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-772837\/v1","author":"N Egbonrelu","year":"2021","unstructured":"Egbonrelu N, Awolola A, Lawanson T, Ogunsola O, Odole-Akinyemi O, Olugbusi J, Akinmoladun A, Babalola O, Ogwara C, Akande P, Olaitan R, Ogunyemi KO, Okonkwo P. Correlates associated with poor viral suppression among children and adolescents accessing antiretroviral therapy in selected health facilities in lagos, Nigeria. Rev. 2021. https:\/\/doi.org\/10.21203\/rs.3.rs-772837\/v1. Preprint.","journal-title":"Rev"},{"key":"11647_CR62","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1007\/s10461-020-02822-4","volume":"24","author":"LK Reif","year":"2020","unstructured":"Reif LK, Abrams EJ, Arpadi S, Elul B, McNairy ML, Fitzgerald DW, et al. Interventions to improve antiretroviral therapy adherence among adolescents and youth in low-and middle-income countries: a systematic review 2015\u20132019. AIDS Behav. 2020;24:2797\u2013810.","journal-title":"AIDS Behav"},{"key":"11647_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-019-6447-4","volume":"19","author":"N Willis","year":"2019","unstructured":"Willis N, Milanzi A, Mawodzeke M, Dziwa C, Armstrong A, Yekeye I, et al. Effectiveness of community adolescent treatment supporters (CATS) interventions in improving linkage and retention in care, adherence to ART and psychosocial well-being: a randomised trial among adolescents living with HIV in rural Zimbabwe. BMC Public Health. 2019;19:1\u20139.","journal-title":"BMC Public Health"},{"issue":"1","key":"11647_CR64","doi-asserted-by":"publisher","first-page":"e0189770","DOI":"10.1371\/journal.pone.0189770","volume":"13","author":"K Ridgeway","year":"2018","unstructured":"Ridgeway K, Dulli LS, Murray KR, Silverstein H, Santo D, Olsen L, et al. Interventions to improve antiretroviral therapy adherence among adolescents in low-and middle-income countries: a systematic review of the literature. PLoS ONE. 2018;13(1):e0189770.","journal-title":"PLoS ONE"},{"key":"11647_CR65","doi-asserted-by":"crossref","unstructured":", Bain-Brickley D, Butler LM, Kennedy GE, Rutherford GW, Cochrane HIV\/AIDS Group. Interventions to improve adherence to antiretroviral therapy in children with HIV infection. Cochrane database of systematic reviews. 1996 Sep 1;2011(12)","DOI":"10.1002\/14651858.CD009513"},{"issue":"2","key":"11647_CR66","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nrmicro.2017.128","volume":"16","author":"LC Bell","year":"2018","unstructured":"Bell LC, Noursadeghi M. Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection. Nat Rev Microbiol. 2018;16(2):80\u201390.","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"11647_CR67","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/2049-632X.12108","volume":"70","author":"EM Shankar","year":"2014","unstructured":"Shankar EM, Vignesh R, Elleg\u00e5rd R, Barathan M, Chong YK, Bador MK, et al. HIV\u2013Mycobacterium tuberculosis co-infection: A \u2018danger-couple model\u2019of disease pathogenesis. Pathog Dis. 2014;70(2):110\u20138.","journal-title":"Pathog Dis"},{"issue":"6","key":"11647_CR68","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/COH.0000000000000495","volume":"13","author":"JA Tornheim","year":"2018","unstructured":"Tornheim JA, Dooley KE. Challenges of TB and HIV co-treatment: updates and insights. Curr Opin HIV AIDS. 2018;13(6):486\u201391.","journal-title":"Curr Opin HIV AIDS"},{"issue":"11","key":"11647_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200242","volume":"13","author":"J Kadima","year":"2018","unstructured":"Kadima J, Patterson E, Mburu M, Blat C, Nyanduko M, Bukusi EA, et al. Adoption of routine virologic testing and correlates of virologic failure among HIV-infected children on antiretroviral treatment in Western Kenya. PLoS ONE. 2018;13(11):e0200242.","journal-title":"PLoS ONE"},{"issue":"06","key":"11647_CR70","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3855\/jidc.13603","volume":"15","author":"FG Samizi","year":"2021","unstructured":"Samizi FG, Panga OD, Mulugu SS, Gitige CG, Mmbaga EJ. Rate and correlates of HIV virological failure among adults on first-line antiretroviral treatment in Dar Es salaam, Tanzania. J Infect Developing Ctries. 2021;15(06):853\u201360. https:\/\/doi.org\/10.3855\/jidc.13603.","journal-title":"J Infect Developing Ctries"},{"issue":"4","key":"11647_CR71","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1177\/2325957413503368","volume":"13","author":"P Memiah","year":"2014","unstructured":"Memiah P, Shumba C, Etienne-Mesubi M, Agbor S, Hossain MB, Komba P, et al. The effect of depressive symptoms and CD4 count on adherence to highly active antiretroviral therapy in sub-Saharan Africa. Journal of the International Association of Providers of AIDS Care (JIAPAC). 2014;13(4):346\u201352.","journal-title":"Journal of the International Association of Providers of AIDS Care (JIAPAC)"},{"issue":"10","key":"11647_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074771","volume":"8","author":"K Whetten","year":"2013","unstructured":"Whetten K, Shirey K, Pence BW, Yao J, Thielman N, Whetten R, et al. Trauma history and depression predict incomplete adherence to antiretroviral therapies in a low income country. PLoS ONE. 2013;8(10):e74771.","journal-title":"PLoS ONE"},{"issue":"1","key":"11647_CR73","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/09540120802032643","volume":"21","author":"LK Murray","year":"2009","unstructured":"Murray LK, Semrau K, McCurley E, Thea DM, Scott N, Mwiya M, et al. Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study. AIDS Care. 2009;21(1):78\u201386.","journal-title":"AIDS Care"},{"issue":"2","key":"11647_CR74","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.socscimed.2008.03.042","volume":"67","author":"SL Nam","year":"2008","unstructured":"Nam SL, Fielding K, Avalos A, Dickinson D, Gaolathe T, Geissler PW. The relationship of acceptance or denial of HIV-status to antiretroviral adherence among adult HIV patients in urban Botswana. Soc Sci Med. 2008;67(2):301\u201310.","journal-title":"Soc Sci Med"},{"issue":"1","key":"11647_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-019-0257-8","volume":"17","author":"P Chan","year":"2020","unstructured":"Chan P, Goh O, Kroon E, Colby D, Sacdalan C, Pinyakorn S, Prueksakaew P, Reiss P, Ananworanich J, Valcour V, Spudich S. Neuropsychiatric outcomes before and after switching to dolutegravir-based therapy in an acute HIV cohort. AIDS Research and Therapy 2020 Jan 7;17(1):1. https:\/\/doi.org\/10.1186\/s12981-019-0257-8","journal-title":"AIDS Res Therapy"},{"key":"11647_CR76","doi-asserted-by":"crossref","unstructured":"Turkova A, White E, Kekitiinwa AR, Mumbiro V, Kaudha E, Liberty A, Ahimbisibwe GM, Moloantoa T, Srirompotong U, Mosia NR, Puthanakit T, Kobbe R, Fortuny C, Kataike H, Bbuye D, Na-Rajsima S, Coelho A, Lugemwa A, Bwakura-D angarembizi MF, Zuidewind P. Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial. The Lancet Child & Adolescent Health. 2023 Oct 1;7(10):718-27","DOI":"10.2139\/ssrn.4380060"},{"key":"11647_CR77","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.18.7.20258","volume":"18","author":"RC Vreeman","year":"2015","unstructured":"Vreeman RC, Scanlon ML, McHenry MS, Nyandiko WM. The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children. J Int AIDS Soc. 2015;18:20258.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"11647_CR78","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s43058-022-00272-8","volume":"3","author":"AD Wagner","year":"2022","unstructured":"Wagner AD, Augusto O, Njuguna IN, Gaitho D, Mburu N, Oluoch G, et al. Systems analysis and improvement approach to optimize the pediatric and adolescent HIV cascade (SAIA-PEDS): a pilot study. Implement Sci Commun. 2022;3(1):49. https:\/\/doi.org\/10.1186\/s43058-022-00272-8.","journal-title":"Implement Sci Commun"},{"key":"11647_CR79","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.childyouth.2019.05.036","volume":"103","author":"WK Luseno","year":"2019","unstructured":"Luseno WK, Iritani BJ, Maman S, Mbai I, Ongili B, Otieno FA, et al. If the mother does not know, there is no way she can tell the adolescent to go for drugs: challenges in promoting health and preventing transmission among pregnant and parenting Kenyan adolescents living with HIV. Child Youth Serv Rev. 2019;103:100\u20136.","journal-title":"Child Youth Serv Rev"},{"issue":"8","key":"11647_CR80","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.4103\/jfmpc.jfmpc_481_19","volume":"8","author":"DD Kadam","year":"2019","unstructured":"Kadam DD, Saurabha U, Tiwari SC. Health needs of adolescent girls living in an urban slum of a metropolitan city-a mixed method approach. J Family Med Prim Care. 2019;8(8):2661\u20136.","journal-title":"J Family Med Prim Care"},{"issue":"1","key":"11647_CR81","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12978-015-0026-7","volume":"12","author":"LM Atuyambe","year":"2015","unstructured":"Atuyambe LM, Kibira SPS, Bukenya J, Muhumuza C, Apolot RR, Mulogo E. Understanding sexual and reproductive health needs of adolescents: evidence from a formative evaluation in Wakiso district, Uganda. Reprod Health. 2015;12(1):35. https:\/\/doi.org\/10.1186\/s12978-015-0026-7.","journal-title":"Reprod Health"},{"key":"11647_CR82","doi-asserted-by":"crossref","unstructured":"Horwood C, Butler LM, Haskins L, Phakathi S, Rollins N. HIV-infected adolescent mothers and their infants: low coverage of HIV services and high risk of HIV transmission in Kwazulu-Natal, South Africa. PLoS ONE. 2013 Sep 20;8(9):e74568.","DOI":"10.1371\/journal.pone.0074568"},{"issue":"1","key":"11647_CR83","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1186\/s12913-018-3623-7","volume":"18","author":"S James","year":"2018","unstructured":"James S, Pisa PT, Imrie J, Beery MP, Martin C, Skosana C, Delany-Moretlwe S. Assessment of adolescent and youth friendly services in primary healthcare facilities in two provinces in South Africa. BMC Health Serv Res. 2018;18(1):809. https:\/\/doi.org\/10.1186\/s12913-018-3623-7.","journal-title":"BMC Health Serv Res"},{"issue":"12","key":"11647_CR84","doi-asserted-by":"publisher","first-page":"e0190260","DOI":"10.1371\/journal.pone.0190260","volume":"12","author":"BC Zanoni","year":"2017","unstructured":"Zanoni BC, Sibaya T, Cairns C, Lammert S, Haberer JE. Higher retention and viral suppression with adolescent-focused HIV clinic in South Africa. PLoS ONE. 2017;12(12):e0190260. https:\/\/doi.org\/10.1371\/journal.pone.0190260.","journal-title":"PLoS ONE"},{"key":"11647_CR85","doi-asserted-by":"crossref","unstructured":"Jacob EA, Osime E, Kolawole F, Titiayo OE. Attitutes and behaviors of healthcare professionals toward HIV positive patients in a tertiary hospital. Biomedical Research and Clinical Reviews. 2022;6(3).","DOI":"10.31579\/2692-9406\/094"},{"key":"11647_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19020745","author":"M Sallam","year":"2022","unstructured":"Sallam M, Alabbadi AM, Abdel-Razeq S, Battah K, Malkawi L, Al-Abbadi MA, et al. HIV knowledge and stigmatizing attitude towards people living with HIV\/AIDS among medical students in Jordan. Int J Environ Res Public Health. 2022. https:\/\/doi.org\/10.3390\/ijerph19020745.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"11647_CR87","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.4102\/sajhivmed.v23i1.1356","volume":"23","author":"BA Elashi","year":"2022","unstructured":"Elashi BA, van Wyk BE. Correlates associated with viral suppression among adolescents on antiretroviral therapy in free state province, South Africa. South Afr J HIV Med. 2022;23(1):1356.","journal-title":"South Afr J HIV Med"},{"issue":"9","key":"11647_CR88","doi-asserted-by":"publisher","first-page":"e0184879","DOI":"10.1371\/journal.pone.0184879","volume":"12","author":"KR Murray","year":"2017","unstructured":"Murray KR, Dulli LS, Ridgeway K, Dal Santo L, de Mora D, Olsen D, et al. Improving retention in HIV care among adolescents and adults in low-and middle-income countries: a systematic review of the literature. PLoS ONE. 2017;12(9):e0184879.","journal-title":"PLoS ONE"},{"key":"11647_CR89","doi-asserted-by":"crossref","unstructured":"Mukumbang FC, Mwale JC, van Wyk B. Conceptualising the correlates affecting retention in care of patients on antiretroviral treatment in Kabwe District, Zambia, using the ecological framework. AIDS Research and Treatment. 2017;2017(1):7356362","DOI":"10.1155\/2017\/7356362"},{"issue":"1","key":"11647_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4102\/sajhivmed.v17i1.476","volume":"17","author":"IN Azia","year":"2016","unstructured":"Azia IN, Mukumbang FC, Van Wyk B. Barriers to adherence to antiretroviral treatment in a regional hospital in Vredenburg, Western Cape, South Africa. South Afr J HIV Med. 2016;17(1):1\u20138.","journal-title":"South Afr J HIV Med"},{"key":"11647_CR91","unstructured":"NAKAZEA RJ. Correlates of hiv viral load suppression among HIV positive adults on care in Nakuru county, Kenya (Doctoral dissertation, KENYATTA UNIVERSITY)."},{"issue":"02","key":"11647_CR92","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4236\/wja.2020.102008","volume":"10","author":"B Oryokot","year":"2020","unstructured":"Oryokot B, Miya Y, Logose B, Ajambo E, Oluka AI, Odoi C, Etukoit BM, Mugenyi L, Mugisha K. Interventions to improve HIV viral load suppression among the adolescents: evidence of improvement science through a quality improvement approach in Eastern Uganda. World J AIDS. 2020;10(02):94\u2013106. https:\/\/doi.org\/10.4236\/wja.2020.102008.","journal-title":"World J AIDS"},{"issue":"1","key":"11647_CR93","doi-asserted-by":"publisher","DOI":"10.4081\/jphia.2011.e2","volume":"2","author":"NA Umar","year":"2011","unstructured":"Umar NA, Hajara MJ, Khalifa M. Reduction of client waiting time using task shifting in an antiretroviral clinic at specialist hospital Bauchi, Nigeria. J Public Health Afr. 2011;2(1):e2. https:\/\/doi.org\/10.4081\/jphia.2011.e2.","journal-title":"J Public Health Afr"},{"issue":"7","key":"11647_CR94","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1089\/apc.2009.0328","volume":"24","author":"RK Wanyenze","year":"2010","unstructured":"Wanyenze RK, Wagner G, Alamo S, Amanyire G, Ouma J, Kwarisima D, et al. Evaluation of the efficiency of patient flow at three HIV clinics in Uganda. AIDS Patient Care STDS. 2010;24(7):441\u20136. https:\/\/doi.org\/10.1089\/apc.2009.0328.","journal-title":"AIDS Patient Care STDS"},{"key":"11647_CR95","doi-asserted-by":"crossref","unstructured":"Nieuwkerk PT, Oort FJ. Self-reported adherence to antiretroviral therapy for HIV -1 infection and virological treatment and response: a meta-analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2005 Apr 1;38(4):445-8. https:\/\/journals.lww.com\/jaids\/fulltext\/2005\/04010\/self_reported_adherence_to_antiretroviral_therapy.10.aspx","DOI":"10.1097\/01.qai.0000147522.34369.12"},{"key":"11647_CR96","doi-asserted-by":"publisher","unstructured":"Torres-Fernandez D, Jim\u00e9nez de Ory S, Fortuny C, Sainz T, Falc\u00f3n D, Bernal E, Jim\u00e9nez MC, Vilasar\u00f3 MN, Epalza C, Navarro M, Ramos JT, Holgu\u00edn \u00c1, Prieto L. & CoRIS and CoRISpe Spanish National cohorts, C. and C.-F. C. W. G. (2022). Integrase inhibitors in children and adolescents: clinical use and resistance. J Antimicrob Chemother, 77(10), 2784\u201392. https:\/\/doi.org\/10.1093\/jac\/dkac259.","DOI":"10.1093\/jac\/dkac259."},{"key":"11647_CR97","doi-asserted-by":"publisher","unstructured":"Townsend CL, O\u2019Rourke J, Milanzi E, Collins IJ, Judd A, Castro H, Vicari M, Jesson J, Leroy V, Renaud F, Penazzato M. Effectiveness and safety of dolutegravir and raltegravir for treating children and adolescents living with HIV: A systematic review. J Int AIDS Soc. 2022;25(11). https:\/\/doi.org\/10.1002\/jia2.25970.","DOI":"10.1002\/jia2.25970"},{"key":"11647_CR98","doi-asserted-by":"publisher","unstructured":"Amuge, P., Lugemwa, A., Wynne, B., Mujuru, H. A., Violari, A., Kityo, C. M., Archary,M., Variava, E., White, E., Turner, R. M., Shakeshaft, C., Ali, S., Nathoo, K. J.,Atwine, L., Liberty, A., Bbuye, D., Kaudha, E., Mngqibisa, R., Mosala, M., \u2026 Zuidewind,P. (2022). Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: Results from the below 14 kg cohort in the randomised ODYSSEY trial. The Lancet HIV, 9(9), e638\u2013e648. https:\/\/doi.org\/10.1016\/S2352-3018(22)00163-1.","DOI":"10.1016\/S2352-3018(22)00163-1."},{"issue":"3","key":"11647_CR99","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/jac\/dkad010","volume":"78","author":"D Kamori","year":"2023","unstructured":"Kamori D, Barabona G, Rugemalila J, Maokola W, Masoud SS, Mizinduko M, et al. Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on ART in Tanzania: findings from a national representative HIV drug resistance survey. J Antimicrob Chemother. 2023;78(3):779\u201387. https:\/\/doi.org\/10.1093\/jac\/dkad010.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"11647_CR100","doi-asserted-by":"publisher","first-page":"e01645","DOI":"10.1128\/AAC.01645-21","volume":"66","author":"C Vavro","year":"2022","unstructured":"Vavro C, Ruel T, Wiznia A, Monta\u00f1ez N, Nangle K, Horton J, Buchanan AM, Stewart EL, Palumbo P. Emergence of resistance in HIV-1 integrase with dolutegravir treatment in a pediatric population from the IMPAACT P1093 study. Antimicrob Agents Chemother. 2022;66(1):e01645\u201321. https:\/\/doi.org\/10.1128\/AAC.01645-21.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"11647_CR101","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/jac\/dkac082","volume":"77","author":"B Revollo","year":"2022","unstructured":"Revollo B, Vi\u00f1uela L, De La Mora L, Garc\u00eda F, Noguera-Juli\u00e1n M, Parera M, Paredes R, Llibre JM. Integrase resistance emergence with dolutegravir\/lamivudine with prior HIV-1 suppression. J Antimicrob Chemother. 2022;77(6):1738\u201340. https:\/\/doi.org\/10.1093\/jac\/dkac082.","journal-title":"J Antimicrob Chemother"},{"key":"11647_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.662894","volume":"12","author":"P Frange","year":"2021","unstructured":"Frange P, Montange T, Le Chenadec J, Batalie D, Fert I, Dollfus C, et al. Impact of early versus late antiretroviral treatment initiation on naive T lymphocytes in HIV-1-infected children and adolescents \u2013 the-ANRS-EP59-CLEAC study. Front Immunol. 2021;12:662894. https:\/\/doi.org\/10.3389\/fimmu.2021.662894.","journal-title":"Front Immunol"}],"updated-by":[{"DOI":"10.1186\/s12879-025-12073-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000}}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11647-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11647-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11647-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T06:35:50Z","timestamp":1762583750000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11647-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11647"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11647-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12879-025-12073-0","URL":"https:\/\/doi.org\/10.1186\/s12879-025-12073-0","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical Approval was granted by Makerere University School of Public Health Research and Ethics Committee (MakSPH-REC) under protocol number 308. MakSPH-REC is accredited by the Uganda National Council for Science and Technology (UNCST). Further approval was granted by Gulu Regional Referral Hospital Research and Ethics Committee (GRRH-REC) under instrument; REC\/2023\/11\/04. All methods were performed in accordance with the Declaration of Helsinki. Verbal and written consent were sought and consent forms were signed for consenting adolescents aged 18 years and above while caregivers consented for those aged 5\u201317 years. Consent was also sought from in-depth and key informant interview participants for audio voice recordings. The adolescents and caregivers were informed of their voluntary nature of participation and free withdrawal from the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"1438"}}